<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font3" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font4" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="2" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font6" size="15" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font7" size="16" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font8" size="16" family="AkzidenzGroteskBE,BoldItalic" color="#000000"/>
	<fontspec id="font9" size="12" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font10" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font11" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font12" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font13" size="9" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font14" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font15" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font16" size="10" family="AkzidenzGroteskBE" color="#000000"/>
<text top="85" left="477" width="78" height="10" font="font0" id="p1_t1" reading_order_no="2" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="42" left="315" width="62" height="7" font="font1" id="p1_t2" reading_order_no="0" segment_no="0" tag_type="text"><b>Available online</b></text>
<text top="42" left="380" width="176" height="7" font="font3" id="p1_t3" reading_order_no="1" segment_no="0" tag_type="text">http://breast-cancer-research.com/content/7/1/R46</text>
<text top="735" left="569" width="14" height="8" font="font4" id="p1_t4" reading_order_no="113" segment_no="25" tag_type="text">R46</text>
<text top="85" left="57" width="9" height="2" font="font5" id="p1_t5" reading_order_no="4" segment_no="2" tag_type="title">Vol 7 No 1</text>
<text top="85" left="57" width="103" height="14" font="font6" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="title">Research article</text>
<text top="102" left="57" width="443" height="14" font="font7" id="p1_t7" reading_order_no="5" segment_no="3" tag_type="title"><b>Breast fibroblasts modulate epithelial cell proliferation in </b></text>
<text top="120" left="57" width="144" height="14" font="font7" id="p1_t8" reading_order_no="6" segment_no="3" tag_type="title"><b>three-dimensional </b></text>
<text top="120" left="201" width="58" height="14" font="font8" id="p1_t9" reading_order_no="7" segment_no="3" tag_type="title"><i><b>in vitro </b></i></text>
<text top="120" left="259" width="77" height="14" font="font7" id="p1_t10" reading_order_no="8" segment_no="3" tag_type="title"><b>co-culture</b></text>
<text top="138" left="57" width="94" height="11" font="font9" id="p1_t11" reading_order_no="9" segment_no="4" tag_type="text">Andrea Sadlonova</text>
<text top="137" left="151" width="5" height="8" font="font3" id="p1_t12" reading_order_no="10" segment_no="4" tag_type="text">1</text>
<text top="138" left="155" width="79" height="11" font="font9" id="p1_t13" reading_order_no="11" segment_no="4" tag_type="text">, Zdenek Novak</text>
<text top="137" left="235" width="5" height="8" font="font3" id="p1_t14" reading_order_no="12" segment_no="4" tag_type="text">2</text>
<text top="138" left="240" width="94" height="11" font="font9" id="p1_t15" reading_order_no="13" segment_no="4" tag_type="text">, Martin R Johnson</text>
<text top="137" left="334" width="5" height="8" font="font3" id="p1_t16" reading_order_no="14" segment_no="4" tag_type="text">3</text>
<text top="138" left="339" width="87" height="11" font="font9" id="p1_t17" reading_order_no="15" segment_no="4" tag_type="text">, Damon B Bowe</text>
<text top="137" left="426" width="5" height="8" font="font3" id="p1_t18" reading_order_no="16" segment_no="4" tag_type="text">3</text>
<text top="138" left="431" width="85" height="11" font="font9" id="p1_t19" reading_order_no="17" segment_no="4" tag_type="text">, Sandra R Gault</text>
<text top="137" left="516" width="5" height="8" font="font3" id="p1_t20" reading_order_no="18" segment_no="4" tag_type="text">1</text>
<text top="138" left="521" width="6" height="11" font="font9" id="p1_t21" reading_order_no="19" segment_no="4" tag_type="text">, </text>
<text top="154" left="57" width="66" height="11" font="font9" id="p1_t22" reading_order_no="20" segment_no="4" tag_type="text">Grier P Page</text>
<text top="153" left="123" width="5" height="8" font="font3" id="p1_t23" reading_order_no="21" segment_no="4" tag_type="text">4</text>
<text top="154" left="128" width="118" height="11" font="font9" id="p1_t24" reading_order_no="22" segment_no="4" tag_type="text">, Jaideep V Thottassery</text>
<text top="153" left="246" width="5" height="8" font="font3" id="p1_t25" reading_order_no="23" segment_no="4" tag_type="text">5</text>
<text top="154" left="251" width="86" height="11" font="font9" id="p1_t26" reading_order_no="24" segment_no="4" tag_type="text">, Danny R Welch</text>
<text top="153" left="337" width="5" height="8" font="font3" id="p1_t27" reading_order_no="25" segment_no="4" tag_type="text">1</text>
<text top="154" left="342" width="96" height="11" font="font9" id="p1_t28" reading_order_no="26" segment_no="4" tag_type="text"> and Andra R Frost</text>
<text top="153" left="438" width="5" height="8" font="font3" id="p1_t29" reading_order_no="27" segment_no="4" tag_type="text">1</text>
<text top="187" left="57" width="3" height="5" font="font10" id="p1_t30" reading_order_no="28" segment_no="5" tag_type="text">1</text>
<text top="187" left="60" width="281" height="7" font="font3" id="p1_t31" reading_order_no="29" segment_no="5" tag_type="text">Department of Pathology, The University of Alabama at Birmingham, Alabama, USA</text>
<text top="196" left="57" width="3" height="5" font="font10" id="p1_t32" reading_order_no="30" segment_no="6" tag_type="text">2</text>
<text top="197" left="60" width="281" height="7" font="font3" id="p1_t33" reading_order_no="31" segment_no="6" tag_type="text">Department of Pediatrics, The University of Alabama at Birmingham, Alabama, USA</text>
<text top="206" left="57" width="3" height="5" font="font10" id="p1_t34" reading_order_no="32" segment_no="7" tag_type="text">3</text>
<text top="206" left="60" width="349" height="7" font="font3" id="p1_t35" reading_order_no="33" segment_no="7" tag_type="text">Department of Pharmacology and Toxicology, The University of Alabama at Birmingham, Alabama, USA</text>
<text top="215" left="57" width="3" height="5" font="font10" id="p1_t36" reading_order_no="34" segment_no="8" tag_type="text">4</text>
<text top="216" left="60" width="289" height="7" font="font3" id="p1_t37" reading_order_no="35" segment_no="8" tag_type="text">Department of Biostatistics, The University of Alabama at Birmingham, Alabama, USA</text>
<text top="225" left="57" width="3" height="5" font="font10" id="p1_t38" reading_order_no="36" segment_no="9" tag_type="text">5</text>
<text top="225" left="60" width="278" height="7" font="font3" id="p1_t39" reading_order_no="37" segment_no="9" tag_type="text">Drug Discovery Division, Southern Research Institute, Birmingham, Alabama, USA</text>
<text top="243" left="57" width="201" height="7" font="font3" id="p1_t40" reading_order_no="38" segment_no="10" tag_type="text">Corresponding author: Andra R Frost, afrost@path.uab.edu</text>
<text top="261" left="57" width="489" height="7" font="font3" id="p1_t41" reading_order_no="39" segment_no="11" tag_type="text">Received: 15 Dec 2003 Revisions requested: 26 Jan 2004 Revisions received: 2 Sep 2004 Accepted: 24 Sep 2004 Published: 8 Nov 2004</text>
<text top="280" left="57" width="65" height="7" font="font11" id="p1_t42" reading_order_no="40" segment_no="12" tag_type="text"><i>Breast Cancer Res</i></text>
<text top="280" left="122" width="25" height="7" font="font3" id="p1_t43" reading_order_no="41" segment_no="12" tag_type="text"> 2005, </text>
<text top="280" left="147" width="4" height="7" font="font2" id="p1_t44" reading_order_no="42" segment_no="12" tag_type="text"><b>7</b></text>
<text top="280" left="152" width="115" height="7" font="font3" id="p1_t45" reading_order_no="43" segment_no="12" tag_type="text">:R46-R59 (DOI 10.1186/bcr949)</text>
<text top="284" left="266" width="44" height="2" font="font5" id="p1_t46" reading_order_no="44" segment_no="12" tag_type="text">http://breast-cancer-research.com/content/7/1/R46</text>
<text top="290" left="57" width="65" height="7" font="font3" id="p1_t47" reading_order_no="45" segment_no="13" tag_type="text">Â© 2004 Sadlonova</text>
<text top="290" left="122" width="17" height="7" font="font11" id="p1_t48" reading_order_no="46" segment_no="13" tag_type="text"><i> et al</i></text>
<text top="290" left="139" width="107" height="7" font="font3" id="p1_t49" reading_order_no="47" segment_no="13" tag_type="text">., licensee BioMed Central Ltd. </text>
<text top="300" left="57" width="495" height="7" font="font3" id="p1_t50" reading_order_no="48" segment_no="14" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License<a href="http://creativecommons.org/licenses/by/2.0"> (http://creativecommons.org/licenses/by/</a></text>
<text top="310" left="57" width="397" height="7" font="font3" id="p1_t51" reading_order_no="49" segment_no="14" tag_type="text"><a href="http://creativecommons.org/licenses/by/2.0">2.0),</a> which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is cited.</text>
<text top="340" left="57" width="43" height="10" font="font12" id="p1_t52" reading_order_no="50" segment_no="15" tag_type="title"><b>Abstract</b></text>
<text top="360" left="57" width="50" height="8" font="font13" id="p1_t53" reading_order_no="51" segment_no="16" tag_type="text"><b>Background</b></text>
<text top="360" left="106" width="147" height="8" font="font14" id="p1_t54" reading_order_no="52" segment_no="16" tag_type="text"> Stromal fibroblasts associated with </text>
<text top="360" left="254" width="29" height="8" font="font15" id="p1_t55" reading_order_no="53" segment_no="16" tag_type="text"><i>in situ </i></text>
<text top="360" left="283" width="14" height="8" font="font14" id="p1_t56" reading_order_no="54" segment_no="16" tag_type="text">and</text>
<text top="370" left="57" width="240" height="8" font="font14" id="p1_t57" reading_order_no="55" segment_no="16" tag_type="text">invasive breast carcinoma differ phenotypically from fibroblasts</text>
<text top="381" left="57" width="240" height="8" font="font14" id="p1_t58" reading_order_no="56" segment_no="16" tag_type="text">associated with normal breast epithelium, and these alterations</text>
<text top="391" left="57" width="240" height="8" font="font14" id="p1_t59" reading_order_no="57" segment_no="16" tag_type="text">in carcinoma-associated fibroblasts (CAF) may promote breast</text>
<text top="402" left="57" width="240" height="8" font="font14" id="p1_t60" reading_order_no="58" segment_no="16" tag_type="text">carcinogenesis and cancer progression. A better understanding</text>
<text top="412" left="57" width="240" height="8" font="font14" id="p1_t61" reading_order_no="59" segment_no="16" tag_type="text">of the changes that occur in fibroblasts during carcinogenesis</text>
<text top="423" left="57" width="240" height="8" font="font14" id="p1_t62" reading_order_no="60" segment_no="16" tag_type="text">and their influence on epithelial cell growth and behavior could</text>
<text top="433" left="57" width="240" height="8" font="font14" id="p1_t63" reading_order_no="61" segment_no="16" tag_type="text">lead to novel strategies for the prevention and treatment of</text>
<text top="444" left="57" width="240" height="8" font="font14" id="p1_t64" reading_order_no="62" segment_no="16" tag_type="text">breast cancer. To this end, the effect of CAF and normal breast-</text>
<text top="454" left="57" width="240" height="8" font="font14" id="p1_t65" reading_order_no="63" segment_no="16" tag_type="text">associated fibroblasts (NAF) on the growth of epithelial cells</text>
<text top="465" left="57" width="237" height="8" font="font14" id="p1_t66" reading_order_no="64" segment_no="16" tag_type="text">representative of pre-neoplastic breast disease was assessed.</text>
<text top="486" left="57" width="36" height="8" font="font13" id="p1_t67" reading_order_no="65" segment_no="18" tag_type="text"><b>Methods</b></text>
<text top="486" left="92" width="205" height="8" font="font14" id="p1_t68" reading_order_no="66" segment_no="18" tag_type="text"> NAF and CAF were grown with the nontumorigenic</text>
<text top="496" left="57" width="240" height="8" font="font14" id="p1_t69" reading_order_no="67" segment_no="18" tag_type="text">MCF10A epithelial cells and their more transformed,</text>
<text top="507" left="57" width="240" height="8" font="font14" id="p1_t70" reading_order_no="68" segment_no="18" tag_type="text">tumorigenic derivative, MCF10AT cells, in direct three-</text>
<text top="517" left="57" width="240" height="8" font="font14" id="p1_t71" reading_order_no="69" segment_no="18" tag_type="text">dimensional co-cultures on basement membrane material. The</text>
<text top="528" left="57" width="240" height="8" font="font14" id="p1_t72" reading_order_no="70" segment_no="18" tag_type="text">proliferation and apoptosis of MCF10A cells and MCF10AT</text>
<text top="538" left="57" width="240" height="8" font="font14" id="p1_t73" reading_order_no="71" segment_no="18" tag_type="text">cells were assessed by 5-bromo-2'-deoxyuridine labeling and</text>
<text top="549" left="57" width="240" height="8" font="font14" id="p1_t74" reading_order_no="72" segment_no="18" tag_type="text">TUNEL assay, respectively. Additionally, NAF and CAF were</text>
<text top="559" left="57" width="240" height="8" font="font14" id="p1_t75" reading_order_no="73" segment_no="18" tag_type="text">compared for expression of insulin-like growth factor II as a</text>
<text top="570" left="57" width="240" height="8" font="font14" id="p1_t76" reading_order_no="74" segment_no="18" tag_type="text">potential mediator of their effects on epithelial cell growth, by</text>
<text top="580" left="57" width="158" height="8" font="font14" id="p1_t77" reading_order_no="75" segment_no="18" tag_type="text">ELISA and by quantitative, real-time PCR.</text>
<text top="360" left="315" width="31" height="8" font="font13" id="p1_t78" reading_order_no="76" segment_no="17" tag_type="text"><b>Results</b></text>
<text top="360" left="346" width="210" height="8" font="font14" id="p1_t79" reading_order_no="77" segment_no="17" tag_type="text"> In relatively low numbers, both NAF and CAF</text>
<text top="370" left="315" width="241" height="8" font="font14" id="p1_t80" reading_order_no="78" segment_no="17" tag_type="text">suppressed proliferation of MCF10A cells. However, only NAF</text>
<text top="381" left="315" width="240" height="8" font="font14" id="p1_t81" reading_order_no="79" segment_no="17" tag_type="text">and not CAF significantly inhibited proliferation of the more</text>
<text top="391" left="315" width="240" height="8" font="font14" id="p1_t82" reading_order_no="80" segment_no="17" tag_type="text">transformed MCF10AT cells. The degree of growth inhibition</text>
<text top="402" left="315" width="240" height="8" font="font14" id="p1_t83" reading_order_no="81" segment_no="17" tag_type="text">varied among NAF or CAF from different individuals. In greater</text>
<text top="412" left="315" width="240" height="8" font="font14" id="p1_t84" reading_order_no="82" segment_no="17" tag_type="text">numbers, NAF and CAF have less inhibitory effect on epithelial</text>
<text top="423" left="315" width="240" height="8" font="font14" id="p1_t85" reading_order_no="83" segment_no="17" tag_type="text">cell growth. The rate of epithelial cell apoptosis was not affected</text>
<text top="433" left="315" width="240" height="8" font="font14" id="p1_t86" reading_order_no="84" segment_no="17" tag_type="text">by NAF or CAF. Mean insulin-like growth factor II levels were not</text>
<text top="444" left="315" width="241" height="8" font="font14" id="p1_t87" reading_order_no="85" segment_no="17" tag_type="text">significantly different in NAF versus CAF and did not correlate</text>
<text top="454" left="315" width="205" height="8" font="font14" id="p1_t88" reading_order_no="86" segment_no="17" tag_type="text">with the fibroblast effect on epithelial cell proliferation.</text>
<text top="496" left="315" width="46" height="8" font="font13" id="p1_t89" reading_order_no="87" segment_no="19" tag_type="text"><b>Conclusion</b></text>
<text top="496" left="361" width="195" height="8" font="font14" id="p1_t90" reading_order_no="88" segment_no="19" tag_type="text"> Both NAF and CAF have the ability to inhibit the</text>
<text top="507" left="315" width="240" height="8" font="font14" id="p1_t91" reading_order_no="89" segment_no="19" tag_type="text">growth of pre-cancerous breast epithelial cells. NAF have</text>
<text top="517" left="315" width="241" height="8" font="font14" id="p1_t92" reading_order_no="90" segment_no="19" tag_type="text">greater inhibitory capacity than CAF, suggesting that the ability</text>
<text top="528" left="315" width="240" height="8" font="font14" id="p1_t93" reading_order_no="91" segment_no="19" tag_type="text">of fibroblasts to inhibit epithelial cell proliferation is lost during</text>
<text top="538" left="315" width="240" height="8" font="font14" id="p1_t94" reading_order_no="92" segment_no="19" tag_type="text">breast carcinogenesis. Furthermore, as the degree of</text>
<text top="549" left="315" width="240" height="8" font="font14" id="p1_t95" reading_order_no="93" segment_no="19" tag_type="text">transformation of the epithelial cells increased they became</text>
<text top="559" left="315" width="240" height="8" font="font14" id="p1_t96" reading_order_no="94" segment_no="19" tag_type="text">resistant to the growth-inhibitory effects of CAF. Insulin-like</text>
<text top="570" left="315" width="240" height="8" font="font14" id="p1_t97" reading_order_no="95" segment_no="19" tag_type="text">growth factor II could not be implicated as a contributor to this</text>
<text top="580" left="315" width="224" height="8" font="font14" id="p1_t98" reading_order_no="96" segment_no="19" tag_type="text">differential effect of NAF and CAF on epithelial cell growth.</text>
<text top="602" left="57" width="40" height="7" font="font2" id="p1_t99" reading_order_no="97" segment_no="20" tag_type="text"><b>Keywords: </b></text>
<text top="602" left="97" width="258" height="7" font="font3" id="p1_t100" reading_order_no="98" segment_no="20" tag_type="text">breast cancer, breast epithelium, fibroblast, insulin-like growth factor, stroma</text>
<text top="641" left="57" width="64" height="10" font="font12" id="p1_t101" reading_order_no="99" segment_no="21" tag_type="title"><b>Introduction</b></text>
<text top="652" left="57" width="240" height="9" font="font16" id="p1_t102" reading_order_no="100" segment_no="23" tag_type="text">The structure and homeostasis of normal breast paren-</text>
<text top="664" left="57" width="240" height="9" font="font16" id="p1_t103" reading_order_no="101" segment_no="23" tag_type="text">chyma is maintained by dynamic interactions between</text>
<text top="676" left="57" width="240" height="9" font="font16" id="p1_t104" reading_order_no="102" segment_no="23" tag_type="text">breast epithelial cells and their associated stroma. These</text>
<text top="641" left="315" width="241" height="9" font="font16" id="p1_t105" reading_order_no="103" segment_no="22" tag_type="text">stromal elements include the vasculature, adipocytes, resi-</text>
<text top="652" left="315" width="241" height="9" font="font16" id="p1_t106" reading_order_no="104" segment_no="22" tag_type="text">dent immune cells, and fibroblasts with their numerous cel-</text>
<text top="664" left="315" width="240" height="9" font="font16" id="p1_t107" reading_order_no="105" segment_no="22" tag_type="text">lular products, including various growth factors and</text>
<text top="676" left="315" width="241" height="9" font="font16" id="p1_t108" reading_order_no="106" segment_no="22" tag_type="text">extracellular matrix (ECM) components. In breast cancers,</text>
<text top="705" left="57" width="490" height="7" font="font3" id="p1_t109" reading_order_no="107" segment_no="24" tag_type="footnote">3D = three-dimensional; BrdU = 5-bromo-2'-deoxyuridine; CAF = carcinoma-associated fibroblasts; CK = cytokeratin; DCIS = ductal carcinoma </text>
<text top="705" left="547" width="9" height="7" font="font11" id="p1_t110" reading_order_no="108" segment_no="24" tag_type="footnote"><i>in </i></text>
<text top="715" left="57" width="12" height="7" font="font11" id="p1_t111" reading_order_no="109" segment_no="24" tag_type="footnote"><i>situ</i></text>
<text top="715" left="69" width="486" height="7" font="font3" id="p1_t112" reading_order_no="110" segment_no="24" tag_type="footnote">; DMEM = Dulbecco's modified Eagle's medium; ECM = extracellular matrix; E:F = ratio of epithelial cells to fibroblasts; ELISA = enzyme-linked </text>
<text top="724" left="57" width="495" height="7" font="font3" id="p1_t113" reading_order_no="111" segment_no="24" tag_type="footnote">immunosorbent assay; FITC = fluorescein isothiocyanate; H&amp;E = hematoxylin and eosin; HPLC = high-performance liquid chromatography; IGF = </text>
<text top="734" left="57" width="473" height="7" font="font3" id="p1_t114" reading_order_no="112" segment_no="24" tag_type="footnote">insulin-like growth factor; NAF = normal breast-associated fibroblasts; PBS = phosphate-buffered saline; PCR = polymerase chain reaction.</text>
</page>
</pdf2xml>
